Insider Trading activities at Pulmonx Corp (LUNG)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pulmonx Corp (LUNG) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pulmonx Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 1127537.

Total stock buying since 2020: $2,012,605.
Total stock sales since 2020: $200,204,021.
Total stock option exercises since 2020: $194,245.


13 insiders reported insider trading activities at Pulmonx Corp (LUNG):
Insider trading activities of Rose Geoffrey Beran
Insider trading activities of Lynch Alissa Hsu
Insider trading activities of Ferrari Richard M
Insider trading activities of Mckune John
Insider trading activities of Boston Scientific Corp
Insider trading activities of Joshi Mehul
Insider trading activities of Florin Daniel P
Insider trading activities of Mead Dana G Jr.
Insider trading activities of French Glendon E. Iii
Insider trading activities of Sung Derrick
Insider trading activities of Williamson Steven S.
Insider trading activities of Melenikiotou Georgia
Insider trading activities of Lehman David Aaron

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Pulmonx Corp (LUNG).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 23,321 $71,362 227,491 $1,350,122 0 $0
2024 14,245 $97,435 130,197 $1,140,964 0 $0
2023 0 $0 92,422 $1,051,984 0 $0
2022 18,014 $95,830 289,962 $6,045,385 49,427 $105,796
2021 4,722 $198,034 4,852,046 $190,615,566 58,178 $88,449
2020 81,576 $1,549,944 0 $0 0 $0

Table 2. Monthly summary of insider trading at Pulmonx Corp (LUNG).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-09 0 $0 33,896 $54,231 0 $0
2025-06 23,321 $71,362 43,388 $136,077 0 $0
2025-03 0 $0 90,207 $661,613 0 $0
2025-02 0 $0 55,453 $468,577 0 $0
2025-01 0 $0 4,547 $29,624 0 $0
2024-12 0 $0 9,873 $61,063 0 $0
2024-11 0 $0 20,000 $132,600 0 $0
2024-10 0 $0 20,000 $130,399 0 $0
2024-09 0 $0 30,351 $231,122 0 $0
2024-08 14,245 $97,435 0 $0 0 $0
2024-06 0 $0 10,956 $75,403 0 $0
2024-05 0 $0 1,184 $10,312 0 $0
2024-04 0 $0 1,184 $8,868 0 $0
2024-03 0 $0 4,281 $39,140 0 $0
2024-02 0 $0 21,184 $308,812 0 $0
2024-01 0 $0 11,184 $143,245 0 $0
2023-12 0 $0 25,479 $287,090 0 $0
2023-11 0 $0 1,184 $12,550 0 $0
2023-10 0 $0 1,184 $9,886 0 $0
2023-09 0 $0 18,545 $186,212 0 $0
2023-08 0 $0 1,184 $12,479 0 $0
2023-07 0 $0 15,000 $190,200 0 $0
2023-06 0 $0 27,376 $326,324 0 $0
2023-03 0 $0 2,470 $27,243 0 $0

Table 3. Detailed insider trading at Pulmonx Corp (LUNG)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-09-02 Joshi Mehul (Chief Financial Officer & PAO) Sale 7,936 1.60 12,697
2025-09-02 Rose Geoffrey Beran (CHIEF COMMERCIAL OFFICER) Sale 6,543 1.60 10,468
2025-09-02 Williamson Steven S. (PRESIDENT AND CEO) Sale 9,648 1.60 15,436
2025-09-02 Lehman David Aaron (GENERAL COUNSEL) Sale 9,769 1.60 15,630
2025-06-12 Ferrari Richard Sale 8,000 3.16 25,280
2025-06-05 Florin Daniel P Buy 23,321 3.06 71,362
2025-06-02 Joshi Mehul (Chief Financial Officer & PAO) Sale 8,061 3.13 25,230
2025-06-02 Rose Geoffrey Beran (CHIEF COMMERCIAL OFFICER) Sale 6,947 3.13 21,758
2025-06-02 Williamson Steven S. (PRESIDENT AND CEO) Sale 9,923 3.13 31,058
2025-06-02 Lehman David Aaron (GENERAL COUNSEL) Sale 10,457 3.13 32,751
2025-03-20 French Glendon E. Iii Sale 20,000 7.85 157,000
2025-03-03 Joshi Mehul (Chief Financial Officer & PAO) Sale 14,384 7.12 102,414
2025-03-03 Rose Geoffrey Beran (CHIEF COMMERCIAL OFFICER) Sale 5,779 7.12 41,175
2025-03-03 Williamson Steven S. (PRESIDENT AND CEO) Sale 27,689 7.14 197,699
2025-03-03 Lehman David Aaron (GENERAL COUNSEL) Sale 22,355 7.31 163,325
2025-02-20 French Glendon E. Iii Sale 55,453 8.45 468,577
2025-01-17 French Glendon E. Iii Sale 2,221 6.50 14,436
2025-01-16 French Glendon E. Iii Sale 2,326 6.53 15,188
2024-12-02 Rose Geoffrey Beran (CHIEF COMMERCIAL OFFICER) Sale 4,376 6.18 27,065
2024-12-02 Lehman David Aaron (GENERAL COUNSEL) Sale 5,497 6.18 33,998
2024-11-22 French Glendon E. Iii Sale 20,000 6.63 132,600
2024-10-17 French Glendon E. Iii Sale 20,000 6.52 130,399
2024-09-12 French Glendon E. Iii Sale 20,000 8.09 161,800
2024-09-03 Rose Geoffrey Beran (CHIEF COMMERCIAL OFFICER) Sale 4,586 6.70 30,726
2024-09-03 Lehman David Aaron (GENERAL COUNSEL) Sale 5,765 6.70 38,596
2024-08-20 Williamson Steven S. (PRESIDENT AND CEO) Buy 14,245 6.84 97,435
2024-06-24 Rose Geoffrey Beran (CHIEF COMMERCIAL OFFICER) Sale 1,184 6.16 7,293
2024-06-03 Rose Geoffrey Beran (CHIEF COMMERCIAL OFFICER) Sale 4,297 6.97 29,950
2024-06-03 Lehman David Aaron (GENERAL COUNSEL) Sale 5,475 6.97 38,160
2024-05-22 Rose Geoffrey Beran (CHIEF COMMERCIAL OFFICER) Sale 1,184 8.71 10,312
2024-04-22 Rose Geoffrey Beran (CHIEF COMMERCIAL OFFICER) Sale 1,184 7.49 8,868
2024-03-22 Rose Geoffrey Beran (CHIEF COMMERCIAL OFFICER) Sale 1,184 9.36 11,082
2024-03-01 Rose Geoffrey Beran (CHIEF COMMERCIAL OFFICER) Sale 3,097 9.06 28,058
2024-02-22 Rose Geoffrey Beran (CHIEF COMMERCIAL OFFICER) Sale 1,184 14.20 16,812
2024-02-15 French Glendon E. Iii (PRESIDENT AND CEO) Sale 20,000 14.60 292,000
2024-01-22 Rose Geoffrey Beran (CHIEF COMMERCIAL OFFICER) Sale 1,184 13.13 15,545
2024-01-18 French Glendon E. Iii (PRESIDENT AND CEO) Sale 10,000 12.77 127,700
2023-12-22 Rose Geoffrey Beran (Chief Commercial Officer) Sale 1,184 12.75 15,096
2023-12-21 French Glendon E. Iii (President and CEO) Sale 10,000 12.42 124,200
2023-12-01 French Glendon E. Iii (President and CEO) Sale 6,676 10.34 69,029
2023-12-01 Rose Geoffrey Beran (Chief Commercial Officer) Sale 2,868 10.34 29,655
2023-12-01 Mckune John (Interim CFO) Sale 942 10.34 9,737
2023-12-01 Lehman David Aaron (General Counsel) Sale 3,809 10.34 39,373
2023-11-22 Rose Geoffrey Beran (Chief Commercial Officer) Sale 1,184 10.60 12,550
2023-10-23 Rose Geoffrey Beran (Chief Commercial Officer) Sale 1,184 8.35 9,886
2023-09-22 Rose Geoffrey Beran (Chief Commercial Officer) Sale 1,184 10.51 12,443
2023-09-01 French Glendon E. Iii (President and CEO) Sale 6,527 10.01 65,335
2023-09-01 Rose Geoffrey Beran (Chief Commercial Officer) Sale 2,843 10.01 28,458
2023-09-01 Sung Derrick (Chief Financial Officer) Sale 4,219 10.01 42,219
2023-09-01 Lehman David Aaron (General Counsel) Sale 3,772 10.01 37,757
2023-08-23 Rose Geoffrey Beran (Chief Commercial Officer) Sale 1,184 10.54 12,479
2023-07-20 French Glendon E. Iii (President and CEO) Sale 15,000 12.68 190,200
2023-06-15 French Glendon E. Iii (President and CEO) Sale 10,000 12.68 126,800
2023-06-01 French Glendon E. Iii (President and CEO) Sale 6,533 11.48 75,018
2023-06-01 Rose Geoffrey Beran (Chief Commercial Officer) Sale 2,845 11.48 32,660
2023-06-01 Sung Derrick (Chief Financial Officer) Sale 4,222 11.49 48,498
2023-06-01 Lehman David Aaron (General Counsel) Sale 3,776 11.48 43,348
2023-03-01 Rose Geoffrey Beran (Chief Commercial Officer) Sale 1,206 11.03 13,302
2023-03-01 Sung Derrick (Chief Financial Officer) Sale 1,264 11.03 13,941
2022-12-01 French Glendon E. Iii (President and CEO) Sale 3,631 5.93 21,531
2022-12-01 Rose Geoffrey Beran (Chief Commercial Officer) Sale 1,055 5.93 6,256
2022-12-01 Sung Derrick (Chief Financial Officer) Sale 1,069 5.93 6,339
2022-12-01 Lehman David Aaron (General Counsel) Sale 1,069 5.93 6,339
2022-11-29 Lynch Alissa Hsu (Director) Buy 1,700 5.51 9,367
2022-11-14 French Glendon E. Iii (President and CEO) Option Ex 10,000 2.20 22,000
2022-11-14 Sung Derrick (Chief Financial Officer) Option Ex 10,000 2.20 22,000
2022-11-08 Ferrari Richard (Director) Buy 10,876 5.30 57,642
2022-09-15 French Glendon E. Iii (President and CEO) Sale 100,000 20.00 2,000,000
2022-08-18 French Glendon E. Iii (President and CEO) Sale 50,000 20.59 1,029,500
2022-06-01 French Glendon E. Iii (President and CEO) Sale 2,523 18.05 45,540
2022-06-01 Rose Geoffrey Beran (Chief Commercial Officer) Sale 1,011 18.05 18,248
2022-06-01 Sung Derrick (Chief Financial Officer) Sale 1,065 18.05 19,223
2022-06-01 Lehman David Aaron (General Counsel) Sale 1,065 18.05 19,223
2022-03-10 Rose Geoffrey Beran (Chief Commercial Officer) Option Ex 29,427 2.10 61,796
2022-03-01 French Glendon E. Iii (President and CEO) Sale 1,132 25.91 29,330
2022-03-01 Rose Geoffrey Beran (Chief Commercial Officer) Sale 426 25.91 11,037
2022-03-01 Sung Derrick (Chief Financial Officer) Sale 458 25.91 11,866
2022-03-01 Lehman David Aaron (General Counsel) Sale 458 25.91 11,866
2022-02-18 French Glendon E. Iii (President and CEO) Sale 12,500 26.97 337,125
2022-02-17 French Glendon E. Iii (President and CEO) Sale 12,500 27.22 340,250
2022-01-21 French Glendon E. Iii (President and CEO) Sale 12,500 24.56 306,962
2022-01-20 French Glendon E. Iii (President and CEO) Sale 12,500 25.98 324,750
2021-12-16 French Glendon E. Iii (President and CEO) Sale 25,000 31.32 783,125
2021-12-15 Rose Geoffrey Beran (Chief Commercial Officer) Sale 22,000 31.00 682,110
2021-12-15 Sung Derrick (Chief Financial Officer) Sale 3,000 31.05 93,150
2021-12-14 Sung Derrick (Chief Financial Officer) Sale 3,000 32.89 98,670
2021-12-01 French Glendon E. Iii (President and CEO) Sale 1,421 32.73 46,509
2021-12-01 Rose Geoffrey Beran (Chief Commercial Officer) Sale 355 32.73 11,619
2021-12-01 Sung Derrick (Chief Financial Officer) Sale 383 32.73 12,535
2021-12-01 Lehman David Aaron (General Counsel) Sale 383 32.73 12,535
2021-11-18 French Glendon E. Iii (President and CEO) Sale 25,000 36.51 912,750
2021-11-15 Rose Geoffrey Beran (Chief Commercial Officer) Sale 7,000 39.94 279,580
2021-10-21 French Glendon E. Iii (President and CEO) Sale 25,000 39.80 995,125
2021-10-15 Rose Geoffrey Beran (Chief Commercial Officer) Sale 7,000 39.44 276,080
2021-09-21 Sung Derrick (Chief Financial Officer) Sale 3,000 37.50 112,500
2021-09-20 French Glendon E. Iii (President and CEO) Sale 23,571 37.66 887,683
2021-09-20 Sung Derrick (Chief Financial Officer) Sale 3,000 37.65 112,935
2021-09-16 French Glendon E. Iii (President and CEO) Sale 25,000 38.86 971,500
2021-09-15 Rose Geoffrey Beran (Chief Commercial Officer) Sale 7,000 38.12 266,840
2021-09-01 French Glendon E. Iii (President and CEO) Sale 1,421 40.09 56,967
2021-09-01 Rose Geoffrey Beran (Chief Commercial Officer) Sale 355 40.09 14,231
2021-09-01 Sung Derrick (Chief Financial Officer) Sale 383 40.09 15,354
2021-09-01 Lehman David Aaron (General Counsel) Sale 383 40.09 15,354
2021-08-19 French Glendon E. Iii (President and CEO) Sale 26,000 36.61 951,860
2021-08-16 Rose Geoffrey Beran (Chief Commercial Officer) Sale 7,000 36.71 256,970
2021-07-15 French Glendon E. Iii (President and CEO) Sale 26,000 38.30 995,930
2021-07-15 French Glendon E. Iii (President and CEO) Option Ex 4,375 2.20 9,625
2021-07-15 Rose Geoffrey Beran (Chief Commercial Officer) Sale 7,000 38.56 269,899
2021-07-13 Boston Scientific Corp (10% Owner) Sale 2,500,000 37.45 93,625,000
2021-07-12 Florin Daniel P (Director) Buy 2,500 40.00 100,000
2021-06-25 Florin Daniel P (Director) Buy 2,222 44.12 98,034
2021-06-17 French Glendon E. Iii (President and CEO) Sale 26,000 42.99 1,117,818
2021-06-17 French Glendon E. Iii (President and CEO) Option Ex 4,375 2.20 9,625
2021-05-24 Rose Geoffrey Beran (Chief Commercial Officer) Sale 4,797 41.34 198,322
2021-05-20 French Glendon E. Iii (President and CEO) Sale 26,000 41.32 1,074,242
2021-05-18 Rose Geoffrey Beran (Chief Commercial Officer) Option Ex 49,428 1.40 69,199
2021-05-10 Rose Geoffrey Beran (Chief Commercial Officer) Sale 4,797 41.67 199,914
2021-04-15 French Glendon E. Iii (President and CEO) Sale 26,000 43.85 1,140,100
2021-04-06 Sung Derrick (Chief Financial Officer) Sale 5,000 47.54 237,685
2021-04-06 Boston Scientific Corp (10% Owner) Sale 650,000 43.60 28,340,000
2021-04-05 Rose Geoffrey Beran (Chief Commercial Officer) Sale 4,797 48.02 230,375
2021-04-05 Sung Derrick (Chief Financial Officer) Sale 5,000 48.06 240,300
2021-03-30 Boston Scientific Corp (10% Owner) Sale 1,350,000 40.80 55,079,999
2020-10-05 Melenikiotou Georgia Buy 26,315 19.00 499,985
2020-10-05 Florin Daniel P Buy 15,789 19.00 299,991
2020-10-05 Mead Dana G Jr. Buy 26,315 19.00 499,985
2020-10-05 Ferrari Richard M Buy 13,157 19.00 249,983

Insider trading activities including stock purchases, stock sales, and option exercises of LUNG listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pulmonx Corp (symbol LUNG, CIK number 1127537) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.